China’s healthcare watchdog to investigate new drugs list after quality issues flagged
China’s healthcare regulator has pledged to investigate the quality of drugs under a new list covered by national insurance, after lawmakers in Shanghai warned that they might be substandard. In a statement on its website on Monday, the National Healthcare Security Administration said it would send a team to Shanghai to seek suggestions, as well … Read more
